Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10049738HBVENSG00000155846.17protein_codingPPARGC1BNoNo133522B7ZM40
Q86YN6
TVIS30063803HIVENSG00000155846.17protein_codingPPARGC1BNoNo133522B7ZM40
Q86YN6
TVIS30063804HIVENSG00000155846.17protein_codingPPARGC1BNoNo133522B7ZM40
Q86YN6
TVIS20059942HPVENSG00000155846.17protein_codingPPARGC1BNoNo133522B7ZM40
Q86YN6
TVIS20060241HPVENSG00000155846.17protein_codingPPARGC1BNoNo133522B7ZM40
Q86YN6
TVIS20059128HPVENSG00000155846.17protein_codingPPARGC1BNoNo133522B7ZM40
Q86YN6
TVIS44022403HTLV-1ENSG00000155846.17protein_codingPPARGC1BNoNo133522B7ZM40
Q86YN6
TVIS44022404HTLV-1ENSG00000155846.17protein_codingPPARGC1BNoNo133522B7ZM40
Q86YN6
TCGA Plot Options
Drug Information
GenePPARGC1B
DrugBank IDDB01118
Drug NameAmiodarone
Target IDBE0009812
UniProt IDQ86YN6
Regulation Typeagonist
PubMed IDs24489787
CitationsSzalowska E, van der Burg B, Man HY, Hendriksen PJ, Peijnenburg AA: Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices. PLoS One. 2014 Jan 29;9(1):e86795. doi: 10.1371/journal.pone.0086795. eCollection 2014.
GroupsApproved; Investigational
Direct ClassificationAryl-phenylketones
SMILESCCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
PathwaysAmiodarone Action Pathway
PharmGKBPA448383
ChEMBLCHEMBL633